Product Categories
| Country: | China |
|---|---|
| Tel: | 0316-2883536 |
| Mobile: | 19333636468 |
| E-mail: | 573487203@qq.com |
| QQ: | 2885506126 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| (Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate | C24H21N3O3 | 1987887-92-2 | Details |
| C17H22FN3O4 | 2842071-59-2 | Details |
| R-Linezolid | C16H20FN3O4 | 872992-20-6 | Details |
| Desacetyl-N,O-descarbonyl Linezolid | C13H20FN3O2 | 333753-72-3 | Details |
| Linezolid N-Oxide | C16H20FN3O5 | 189038-36-6 | Details |
| Bis-Linezolid | C30H35F2N5O7 | 908143-04-4 | Details |
| 2-OXO-2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLIC ACID ETHYL ESTER | C11H11NO3 | 954239-49-7 | Details |
| (S)-N-(3-Chloro-2-hydroxypropyl)acetamide | C5H10ClNO2 | 224323-47-1 | Details |
| (S)-5-((Tert-butylamino)methyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one | C18H26FN3O3 | 1215006-08-8 | Details |
| N-[[(5S)-3-[4-(4-Morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]Methyl]acetaMide | C16H21N3O4 | 556801-15-1 | Details |
| N-[(2R)-3-[[3-Fluoro-4-(4-morpholinyl)phenyl]amino]-2-hydroxypropyl]acetamide | C15H22FN3O3 | 333753-67-6 | Details |
| Linezolid Related Compound B | C16H20FN3O3S | 216868-57-4 | Details |
| (5S,5'S)-5,5'-(azanediylbis(methylene))bis(3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one) | C28H33F2N5O6 | 2307625-63-2 | Details |
| Glycine, N-methyl-N-(4-nitrophenyl)- | C9H10N2O4 | 98953-48-1 | Details |
| N-Acetyl Nintedanib | C33H35N5O5 | 2380229-45-6 | Details |
| C12H11NO5 | 2514952-69-1 | Details |
| Nintedanib impurity I | C30H31N5O4 | 334951-61-0 | Details |
| C16H22FN3O3 | 3054252-47-7 | Details |
| Lifitegrast Impurity 30 | C27H26Cl2N2O5S | 1194864-18-0 | Details |
| Lifitegrast Impurity 29 | C25H28Cl2N2O7S | 2762168-17-0 | Details |
| 1H-Indole-6-carboxylic acid, 3-[[[4-[(2-chloroacetyl)methylamino]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-, methyl ester, (3Z)- | C26H22ClN3O4 | 1987887-93-3 | Details |
| Linezolid Impurity 12 | C20H28FN3O4 | 1215006-11-3 | Details |
| 1H-Indole-6-carboxylic acid, 2,3-dihydro-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene]-2-oxo-, ethyl ester | C32H35N5O4 | 2295911-98-5 | Details |
| C15H20FN3O3 | 3054252-48-8 | Details |
| Nintedanib | C31H33N5O4 | 656247-17-5 | Details |
| Nintedanib impurity G | C30H31N5O4 | 894783-61-0 | Details |
| Nintedanib impurity 03 | C56H52N8O8 | 2410284-90-9 | Details |
| (S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one | C14H18FN3O3 | 168828-90-8 | Details |
| INDEX NAME NOT YET ASSIGNED | C22H26N6O6 | 2410649-54-4 | Details |
| Linezolid Impurity (N,O-Desethylene Linezolid) | C14H18FN3O4 | 1219708-30-1 | Details |
| 4-methyl-N-(4-nitrophenyl)-1-Piperazineacetamide | C13H18N4O3 | 708279-23-6 | Details |
| Nidanib Impurity 7 | C13H20N4O | 262368-25-2 | Details |
| N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide | C14H20N4O3 | 1139453-98-7 | Details |
| Dabigatran iMpurity O | C27H28N6O4 | 948551-71-1 | Details |
| (Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate | C17H13NO4 | 2093243-16-2 | Details |
| C22H22N2O3 | 2102162-79-6 | Details |
| Nintedanib Impurity 107 | C9H8Cl2N2O3 | 78466-25-8 | Details |
| N-[(4-tert.butoxycarbonyl-piperazin-1-yl)-methylcarbonyl]-N-methyl-p-phenylenediamine | C18H28N4O3 | 652140-02-8 | Details |
| Dabigatran Etexilate Impurity O HCl | C27H30ClN7O3 | 211914-50-0 | Details |
| BIBF 1202 | C30H31N5O4 | 894783-71-2 | Details |
| Nintedanib | C20H16ClNO5 | 1174335-83-1 | Details |
| 2519816-53-4 | Details |
| (Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylic acid compound with 3-benzoyl-2-oxoindoline-6-carboxylic acid | C16H11NO4 | 1253768-91-0 | Details |
| Nintedanib Impurity 52 | C22H30N6O2 | 2410284-89-6 | Details |
| Acetamide, 2,2,2-trichloro-N-methyl-N-(4-nitrophenyl)- | C9H7Cl3N2O3 | 126434-07-9 | Details |
| 1-Piperazinecarboxylic acid, 4-[2-[methyl(4-nitrophenyl)amino]-2-oxoethyl]-, 1,1-dimethylethyl ester | C18H26N4O5 | 1277571-69-3 | Details |
| N-(4-Nitrophenyl)-2,2,2-trichloroacetamide | C8H5Cl3N2O3 | 4306-32-5 | Details |
| (E)-Methyl 1-acetyl-3-(Methoxy(phenyl)Methylene)-2-oxoindoline-6-carboxylate | C20H17NO5 | 1168152-07-5 | Details |
| 4-Amino-N-methylaniline | C7H12Cl2N2 | 5395-70-0 | Details |
| N1-(4-NITROPHENYL)-2-CHLOROACETAMIDE | C8H7ClN2O3 | 17329-87-2 | Details |
| N-(4-aMinophenyl)-2-chloro-N-MethylacetaMide | C9H11ClN2O | 855860-75-2 | Details |
| 2-CHLORO-N-METHYL-N-(4-NITROPHENYL)ACETAMIDE | C9H9ClN2O3 | 2653-16-9 | Details |
| Dabigatran Impurity p | C32H36N6O6 | 1408238-37-8 | Details |
| Nintedanib Impurity 35 | C10H9NO4 | 1895918-24-7 | Details |
| Acetamide, 2-chloro-N-methyl-N-(2-nitrophenyl)- | C9H9ClN2O3 | 2653-15-8 | Details |
| Acetamide, 2-hydroxy-N-methyl-N-(4-nitrophenyl)- | C9H10N2O4 | 1860012-61-8 | Details |
| Nintedanib Impurity 57 | C9H10Cl2O2 | 130652-10-7 | Details |
| Nintedanib Impurity 30 | C13H18N4O3 | 1038972-16-5 | Details |
| C12H11NO4 | 676326-36-6 | Details |
| N-ACETYLOXINDOLE 97 | C10H9NO2 | 21905-78-2 | Details |
| 1-Piperazineacetamide, N-(4-aminophenyl)-N-methyl- | C13H20N4O | 2243384-71-4 | Details |
| Dabigatran Impurity 16 | C26H24N6O3 | 211916-39-1 | Details |
| Dabigatran iMpurity F | C19H20N4O4 | 1642853-67-5 | Details |
| INDEX NAME NOT YET ASSIGNED | C28H28N6O3 | 2518152-88-8 | Details |
| 3052343-45-7 | Details |
| Dabigatran Impurity 29 | C35H43N7O5 | 1610758-21-8 | Details |
| Dabigatran Impurity 38 | C30H33N7O5 | 1416446-40-6 | Details |
| β-Alanine, N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, methyl ester | C26H27N7O3 | 771459-37-1 | Details |
| Dabigatran iMpurity K | C32H38N8O4 | 1580491-16-2 | Details |
| Dabigatran Impurity 18 | C21H23N3O4 | 1422435-35-5 | Details |
| Dabigatran etexilate C5 | C33H39N7O5 | 1416446-45-1 | Details |
| Dabigatran Etexilate Impurity X | C25H26N8O2 | 1643377-48-3 | Details |
| Dabigatran Impurity 9 | C19H21N5O2 | 1408238-41-4 | Details |
| 3-Amino-4-(carboxymethyl)benzoic acid | C9H9NO4 | 1373232-85-9 | Details |
| β-Alanine, N-[[2-[[[4-[(E)-amino[[[(4-methylpentyl)oxy]carbonyl]imino]methyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester | C34H41N7O5 | 1873316-88-1 | Details |
| Dabigatran iMpurity D | C34H41N7O5 | 1610758-22-9 | Details |
| Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate | C26H33N5O4 | 2768270-28-4 | Details |
| Dabigatran Impurity 10 (DABRC-10) | C35H43N7O5 | 1304574-20-6 | Details |
| Desethyl Dabigatran Etexilate | C32H37N7O5 | 212321-78-3 | Details |
| Dabigatran iMpurity L | C27H28N6O4 | 1422435-41-3 | Details |
| Dabigatran etexilate Imp.C | C34H40N6O6 | 1408238-40-3 | Details |
| 2-OXO-2,3-DIHYDRO-1H-INDOLE-6-CARBOXYLIC ACID | C9H7NO3 | 334952-09-9 | Details |
| Dabigatran Etexilate iMpurity C4 | C32H37N7O5 | 1416446-43-9 | Details |
| Dabigatran etexilate | C34H41N7O5 | 211915-06-9 | Details |
| Dabigatran Etexilate iMpurity H | C19H20N4O3 | 1702936-92-2 | Details |
| Dabigatran Impurity 10 | C21H24N4O3 | 1422435-37-7 | Details |
| Nintedanib Impurity 59 | C9H11ClO2 | 70380-66-4 | Details |
| Dabigatran Impurity | C26H32N4O5 | 1807758-61-7 | Details |
| Dabigatran Etexilate iMpurity O | C35H43N7O5 | 1349500-09-9 | Details |
| Dabigatran iMpurity E | C20H22N4O3 | 1456889-80-7 | Details |
| Dabigatran Impurity 24 | C38H49N7O5 | 2243727-83-3 | Details |
| Nintedanib impurity E | C29H31N5O2 | 262366-32-5 | Details |
| Dabigatran Etexilate Impurity 64 | C9H10N2O3 | 355809-32-4 | Details |
| 1H-Benzimidazole-5-carboxylic acid, 2-[[(4-cyanophenyl)amino]methyl]-1-methyl-, methyl ester | C18H16N4O2 | 1970195-83-5 | Details |
| Dabigatran Etexilate iMpurity I | C14H21N3O2 | 255706-13-9 | Details |
| Dabigatran Etexilate Impurity H | C33H39N7O5 | 211915-00-3 | Details |
| Dabigatran Etexilate iMpurity 1 | C35H43N7O5 | 1610758-19-4 | Details |
| Dabigatran etexilate Impurity R | C34H41N7O5 | 1610758-20-7 | Details |
| Dabigatran Impurity 5 | C34H41N7O5 | 2225986-95-6 | Details |
| Dabigatran Impurity 19 | C34H41N7O5 | 2225986-94-5 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 | ||||